Cardiometabolic risk factors assessed by a finger stick dried blood spot method

Journal of Diabetes Science and Technology

Volumn 2, Issue 2, 2008, Pages 236-241

  Kapur, Sanjay ^a   Kapur, Sonia ^a   Zava, David ^a  

^a ZRT Laboratory   (United States)

Author keywords

Assay method; Automated; Blood spot; C reactive protein; Cardiometabolic panel; Cardiovascular disease; CRP; Dried blood spot; High sensitivity CRP; Hs CRP; Insulin; Metabolic syndrome; Risk factors; Screening; Triglycerides; Type 2 diabetes

Indexed keywords

EID: 79961167706     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229680800200210     Document Type: Article

References (17)

1. Watson K. Managing cardiometabolic risk: an evolving approach to patient care. Crit Pathw Cardiol. 2007;6(1):5-14.
2. Pescatello LS, Vanheest JL. Physical activity mediates a healthier body weight in the presence of obesity. Br J Sports Med. 2000;34(2):86-93.
3. Sowers JR, Epstein M, Frohlich ED. Diabetes, hypertension and cardiovascular disease: an update. Hypertension. 2001;37(4):1053-9.
4. Quraishi R, Lakshmy R, Prabhakaran D, Mukhopadhyay AK, Jailkhani B. Use of flter paper stored dried blood for measurement of triglycerides. Lipids Health Dis. 2006;5:20.
5. McDade TW, Burhop J, Dohnal J. High sensitivity enzyme immunoassay for C-reactive protein in dried blood spots. Clin Chem. 2004;50(3):652-4.
6. Shields BM, Knight B, Shakespeare L, Babrah J, Powell RJ, Clark PM, Hattersley AT. Determinants of insulin concentrations in healthy 1-week-old babies in the community: applications of a bloodspot assay.. Early Hum Dev. 2006;82(2):143-8.
7. Cordon SM, Elborn JS, Hiller EJ, Shale DJ. C-reactive protein measured in dried blood spots from patients with cystic fbrosis. J Immunol Methods. 1991;143(1):69-72.
8. Butter NL, Hattersley AT, Clark PM. Development of a bloodspot assay for insulin. Clin Chim Acta. 2001;310(2):141-50.
9. Beesley R, Al Serouri A, Filteau SM. Measurement of C-reactive protein in dried blood sports on filter paper. Trans R Soc Trop Med Hyg. 2000;94(3):348-9.
10. Skogstrand K, Thorsen P, Norgaard-Pedersen B, Schendel DE, Sorensen LC, Hougaard DM. Simultaneous measurement of 25 inflammatory markers and neurotrophins in neonatal dried blood spots by immunoassay with xMAP technology.. Clin Chem. 2005;51(10):1854-66.
11. Dowlati B, Dunhardt PA, Smith MM, Shaheb S, Stuart CA. Quantification of insulin in dried blood spots. J Lab Clin Med. 1998;131(4):370-4.
12. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome and the risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women.. Circulation. 2003;107(3):391-7.
13. Marques-Vidal P, Mazoyer E, Bongard V, Gourdy P, Ruidavets JB, Drouet L, Ferrieres J. Prevalence of insulin resistance syndrome in southwestern France and its relationship with infammatory and hemostatic markers.. Diabetes Care. 2002;25(8):1371-7.
14. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6 and risk of developing type 2 diabetes mellitus. JAMA. 2001;286(3):327-34.
15. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC Jr, Taubert K, Tracy R P, Vinicor F; Centers for Disease Control and Prevention; American Heart Association. Markers of infammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.. Circulation. 2003;107(3):499-511.
16. Hokanson JE, Austin MA. Plasma triglyceride is a risk factor for cardiovascular disease independent of HDL cholesterol level. A meta-analysis of population-based prospective studies. J Cardiovasc Risk. 1996;3(2):213-9.
17. Dennis LS. Triglyceride as a risk factor for coronary artery disease. Am J Cardio. 1998;82:49U-59U.